• Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Ma... AOL.com Fri, 10 Jul 2026 09:08:15 GMT
• A Quick Look at Today's Ratings for TScan Therapeutics(TCRX.US), With a Forecast Between $5 to $7 Moomoo Thu, 09 Jul 2026 06:56:56 GMT
• TScan Therapeutics (TCRX) Hovers Near Key Support as Price Declines Marginally - MFI Divergence dars.gov.et Mon, 06 Jul 2026 22:30:40 GMT
• Enterprise value to EBITDA forward of TScan Therapeutics, Inc. – NASDAQ:TCRX TradingView Sat, 04 Jul 2026 11:32:44 GMT
• enterprise value to ebit forward of tscan therapeutics, inc. – nasdaq:tcrx TradingView Wed, 01 Jul 2026 05:06:32 GMT
• TScan Therapeutics at H.C. Wainwright: phase iii push gains pace Investing.com Tue, 30 Jun 2026 07:00:00 GMT
• a quick look at today's ratings for tscan therapeutics(tcrx.us), with a forecast between $5 to $7 富途牛牛 Sat, 27 Jun 2026 04:28:00 GMT
• enterprise value to revenue forward of tscan therapeutics, inc. – nasdaq:tcrx TradingView Fri, 26 Jun 2026 13:41:59 GMT
• price to earnings forward of tscan therapeutics, inc. – boats:tcrx TradingView Fri, 26 Jun 2026 11:33:49 GMT
• tscan therapeutics, inc. (tcrx) reports q1 loss, lags revenue estimates MSN Fri, 26 Jun 2026 08:24:14 GMT
• tscan therapeutics, inc. actuals & estimates (nasdaq:tcrx) TradingView Thu, 25 Jun 2026 22:26:21 GMT
• TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference Yahoo Finance Wed, 24 Jun 2026 07:00:00 GMT
• tcrx reiterated by wedbush -- price target maintained at $5.00 GuruFocus Tue, 23 Jun 2026 16:59:01 GMT
• tcrx reiterated by needham -- price target maintained at $6.00 GuruFocus Tue, 23 Jun 2026 16:54:55 GMT
• TScan Therapeutics: Early ALLOHA Phase 1 Efficacy and Safety Reinforce Late-Stage Plans; Buy Rating and $6 Price Target Maintained... TipRanks Tue, 23 Jun 2026 15:21:34 GMT
• a quick look at today's ratings for tscan therapeutics(tcrx.us), with a forecast between $5 to $7 Moomoo Tue, 23 Jun 2026 13:00:03 GMT
• tscan therapeutics price target maintained with a $6.00/share by needham Moomoo Tue, 23 Jun 2026 12:52:03 GMT
• tscan therapeutics: alloha data, streamlined manufacturing bolster buy rating with $7 price target maintained TipRanks Tue, 23 Jun 2026 11:38:45 GMT
• h.c. wainwright maintains tscan therapeutics(tcrx.us) with buy rating, maintains target price $7 Moomoo Tue, 23 Jun 2026 11:01:13 GMT
• needham maintains tscan therapeutics(tcrx.us) with buy rating, maintains target price $6 Moomoo Tue, 23 Jun 2026 10:53:37 GMT
• tscan therapeutics announces positive initial data from cohort c of ongoing alloha™ phase 1 study evaluating tsc-101 in patients w... Sahm Tue, 23 Jun 2026 07:55:23 GMT
• H.C. Wainwright reiterates Tscan stock rating on trial data Investing.com Tue, 23 Jun 2026 07:00:00 GMT
• tscan therapeutics presents data from cohort c of alloha trial TipRanks Mon, 22 Jun 2026 12:59:16 GMT
• form 8k tscan therapeutics inc for: 22 june by investing.com Investing.com UK Mon, 22 Jun 2026 11:22:00 GMT
• tcrx: cohort c results support advancing tsc-101 to phase 3, showing high efficacy and safety TradingView Mon, 22 Jun 2026 11:15:59 GMT
• TScan says 11 of 14 patients hit complete donor chimerism after TSC-101 Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• TScan Therapeutics Announces Positive Initial Data from GlobeNewswire Mon, 22 Jun 2026 07:00:00 GMT
• TScan Therapeutics (TCRX) shows strong TSC-101 Phase 1 data, plans pivotal trial Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• TScan reports trial data for blood cancer treatment TSC-101 Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• number of shareholders of tscan therapeutics, inc. – nasdaq:tcrx TradingView Sat, 20 Jun 2026 06:05:45 GMT
• TScan Therapeutics (TCRX) Edges Higher Amid Support Test: Key Levels to Watch - Fibonacci Time Zone dars.gov.et Fri, 19 Jun 2026 07:00:00 GMT
• tscan therapeutics inc (tcrx) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 20:34:12 GMT
• tscan therapeutics inc (tcrx) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 20:33:12 GMT
• tscan therapeutics inc (tcrx) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 20:28:22 GMT
• tscan therapeutics inc (tcrx) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 10:25:14 GMT
• tscan therapeutics inc (tcrx) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 10:21:00 GMT
• tscan therapeutics inc (tcrx) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 10:18:36 GMT
• tscan therapeutics inc (tcrx) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 10:16:53 GMT
• tscan therapeutics inc (tcrx) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 10:16:48 GMT
• tscan therapeutics (tcrx) declines sharply as biotech sector headwinds intensify - sector sentiment newsline.com Tue, 16 Jun 2026 23:30:14 GMT
• tcrx q1 2026 earnings: eps miss weighs on shares as pre-revenue biotech continues pipeline development - guidance upgrade report newsline.com Tue, 16 Jun 2026 17:34:47 GMT
• tcrx q1 2026 earnings: eps misses estimates as pre-revenue biotech advances clinical pipeline newsline.com Fri, 12 Jun 2026 02:40:34 GMT
• cellares and tscan collaborate to automate manufacturing of cancer therapies BioProcess International Thu, 04 Jun 2026 22:07:40 GMT
• Cellares and TScan to assess automated manufacturing of TSC-101 therapy Pharmaceutical Technology Thu, 04 Jun 2026 07:00:00 GMT
• Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Ma... Business Wire Wed, 03 Jun 2026 07:00:00 GMT
• Cellares and TScan Agree to Evaluate Automated Manufacturing TSC-101 for Patients with Hematologic Malignancies Genetic Engineering and Biotechnology News Wed, 03 Jun 2026 07:00:00 GMT
• Cellares, TScan to evaluate automated manufacturing for TSC-101 Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• tscan therapeutics, cellares enter agreement to evaluate tcs-101 manufacturing TipRanks Wed, 03 Jun 2026 07:00:00 GMT
• tcrx q1 2026 earnings: wider-than-expected loss as pipeline advances without revenue - financial summary newsline.com Wed, 03 Jun 2026 06:47:15 GMT
• TScan Therapeutics, Inc. (TCRX) Reports Q1 2026 Results With Improved Net Loss Yahoo Finance Tue, 02 Jun 2026 07:00:00 GMT
• tscan therapeutics cuts net loss to 28 million dollars asatunews.co.id Tue, 02 Jun 2026 07:00:00 GMT
• tscan therapeutics q1 2026 earnings: wider-than-expected loss as pre-revenue biotech advances clinical pipeline - eps growth repor... The Legal Advocate Fri, 29 May 2026 17:48:24 GMT
• tscan therapeutics (tcrx) rallies 3.9% as shares test key resistance levels - percent below ma The Legal Advocate Mon, 25 May 2026 14:34:10 GMT
• tscan therapeutics q1 2026 earnings: narrowing loss despite eps miss, stock gains on pipeline progress - forward guidance trends newsline.com Sun, 24 May 2026 07:00:00 GMT
• tscan therapeutics expands authorized shares after stockholder vote The Globe and Mail Sat, 23 May 2026 07:00:00 GMT
• tscan therapeutics analyst ratings and price targets | nasdaq:tcrx Benzinga Fri, 22 May 2026 22:34:00 GMT
• TScan Therapeutics (TCRX) director granted stock options for 67,000 shares Stock Titan Fri, 22 May 2026 07:00:00 GMT
• baker-linked tscan (tcrx) director granted 67,000 stock options Stock Titan Fri, 22 May 2026 07:00:00 GMT
• tscan therapeutics (nasdaq: tcrx) wins vote to double authorized common stock Stock Titan Fri, 22 May 2026 07:00:00 GMT
• tscan therapeutics (tcrx) director awarded 67,000 stock options at $0.9946 Stock Titan Fri, 22 May 2026 07:00:00 GMT
• tscan therapeutics (tcrx) director receives 67,000 stock option grant Stock Titan Fri, 22 May 2026 07:00:00 GMT
• director at tscan therapeutics (nasdaq: tcrx) granted 67,000 options Stock Titan Fri, 22 May 2026 07:00:00 GMT
• tscan therapeutics expands authorized shares after stockholder vote TipRanks Fri, 22 May 2026 07:00:00 GMT
• tscan therapeutics (tcrx) q1 2026 miss: what went wrong - guidance accuracy score newsline.com Wed, 20 May 2026 07:00:00 GMT
• tscan therapeutics (tcrx) stock analysis: +3.27% gain — what to watch 2026-05-20 - money flow newsline.com Wed, 20 May 2026 07:00:00 GMT
• tscan therapeutics (tcrx) q1 2026 earnings miss by significant: key takeaways - non-gaap earnings Newser Tue, 19 May 2026 02:48:38 GMT
• tscan therapeutics (tcrx) at $1.00 — buy, sell, or hold? 2026-05-18 - price surge stocks The Legal Advocate Mon, 18 May 2026 07:00:00 GMT
• tscan therapeutics (tcrx) q1 2026 earnings miss by significant: key takeaways - eps consistency score The Legal Advocate Mon, 18 May 2026 07:00:00 GMT
• bvf group reports near‑10% stake in tscan therapeutics (nasdaq: tcrx) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• intellia: was i right? tscan therapeutics, peptides, sprb stock, merck, bitcoin | martin shkreli (18am7haydg) fathomjournal.org Mon, 11 May 2026 16:07:20 GMT
• tcrx sec filings - tscan therapeutics, inc. 10-k, 10-q, 8-k forms Stock Titan Sun, 10 May 2026 23:13:24 GMT
• lifesci capital maintains tscan therapeutics(tcrx.us) with buy rating, maintains target price $6 富途牛牛 Sat, 09 May 2026 07:00:00 GMT
• tscan therapeutics (nasdaq:tcrx) cut to "strong sell" at wall street zen MarketBeat Sat, 09 May 2026 07:00:00 GMT
• the fundamentals driving tscan therapeutics (tcrx) everyone should understand (under pressure) 2026-05-08 newser.com Sat, 09 May 2026 04:31:03 GMT
• wedbush maintains tscan therapeutics(tcrx.us) with buy rating, maintains target price $5 Moomoo Sat, 09 May 2026 00:48:00 GMT
• tscan therapeutics, inc. (tcrx) reports q1 loss, lags revenue estimates MSN Fri, 08 May 2026 14:39:48 GMT
• the fundamentals driving tscan therapeutics (tcrx) everyone should understand (under pressure) 2026-05-08 - large cap trends newsline.com Fri, 08 May 2026 07:00:00 GMT
• wedbush maintains tscan therapeutics(tcrx.us) with buy rating, maintains target price $5 富途牛牛 Fri, 08 May 2026 07:00:00 GMT
• tscan therapeutics reports first quarter 2026 financial results and provides corporate update Black Hills Pioneer Thu, 07 May 2026 09:00:00 GMT
• tscan therapeutics announces q1 2026 financial results, phase 3 tsc-101 trial launch, and pipeline updates Minichart Thu, 07 May 2026 07:00:00 GMT
• buy rating reiterated on tsc-101 ahead of key alloha readouts and pipeline expansion; $6 price target maintained TipRanks Thu, 07 May 2026 07:00:00 GMT
• tscan therapeutics, inc. 2026 q1 10-q report: financials, risk factors, and forward-looking statements Minichart Thu, 07 May 2026 07:00:00 GMT
• tscan therapeutics, inc. 2026 q1 10-q report: financials, risk factors, and forward-looking statements Minichart Wed, 06 May 2026 19:28:00 GMT
• tscan therapeutics announces q1 2026 financial results, phase 3 tsc-101 trial launch, and pipeline updates Minichart Wed, 06 May 2026 16:16:00 GMT
• tscan therapeutics inc reports results for the quarter ended march 31 - earnings summary TradingView Wed, 06 May 2026 15:03:36 GMT
• tscan therapeutics reports $175.3 million in cash reserves, funding operations into second half of 2028 geneonline.com Wed, 06 May 2026 11:38:27 GMT
• tscan therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Wed, 06 May 2026 11:31:00 GMT
• TScan Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire Wed, 06 May 2026 07:00:00 GMT
• TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates Yahoo Finance Wed, 06 May 2026 07:00:00 GMT
• tscan lines up phase 3 blood cancer study as patient data nears Stock Titan Wed, 06 May 2026 07:00:00 GMT
• tcrx financials: income statement, balance sheet & cash flow | tscan therapeutics, inc. Stock Titan Wed, 06 May 2026 07:00:00 GMT
• needham maintains tscan therapeutics(tcrx.us) with buy rating, maintains target price $6 Moomoo Wed, 06 May 2026 07:00:00 GMT
• h.c. wainwright maintains tscan therapeutics(tcrx.us) with buy rating, maintains target price $7 Moomoo Wed, 06 May 2026 07:00:00 GMT
• tscan therapeutics (nasdaq: tcrx) narrows q1 loss, plans phase 3 Stock Titan Wed, 06 May 2026 07:00:00 GMT
• tscan therapeutics, inc. 1q 2026: revenue $982k, eps $(0.22) — 10-q summary TradingView Wed, 06 May 2026 07:00:00 GMT
• context therapeutics reports first quarter 2026 operating and financial results Yahoo Finance Wed, 06 May 2026 07:00:00 GMT
• tscan therapeutics (nasdaq: tcrx) narrows q1 2026 loss as r&d declines and cash runway extends Stock Titan Wed, 06 May 2026 07:00:00 GMT
• tscan therapeutics (nasdaq:tcrx) releases quarterly earnings results, hits expectations MarketBeat Wed, 06 May 2026 07:00:00 GMT
• tscan therapeutics, inc. (nasdaq:tcrx) receives average rating of "hold" from brokerages MarketBeat Tue, 05 May 2026 07:00:00 GMT
• is tscan therapeutics (tcrx) stock worth taking a position in newsline.com Wed, 29 Apr 2026 07:00:00 GMT
• tscan therapeutics (tcrx) expected to announce quarterly earnings on tuesday MarketBeat Tue, 28 Apr 2026 12:41:12 GMT
• TScan brings post-transplant cancer relapse research to Boston meeting Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting Yahoo Finance Mon, 27 Apr 2026 07:00:00 GMT
• is institutional money buying tscan therapeutics (tcrx) stock | q4 2025: profit exceeds views - p/e ratio Cổng thông tin điện tử tỉnh Tây Ninh Thu, 23 Apr 2026 01:26:56 GMT
• is institutional money buying tscan therapeutics (tcrx) stock | q4 2025: profit exceeds views - stability report Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 20:14:18 GMT
• tcrx financials: income statement, balance sheet & cash flow | tscan therapeutics, inc. Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
• is institutional money buying tscan therapeutics (tcrx) stock | q4 2025: profit exceeds views - basic eps analysis newsline.com Tue, 21 Apr 2026 07:00:00 GMT
• lifesci capital maintains tscan therapeutics(tcrx.us) with buy rating, maintains target price $6 Moomoo Mon, 20 Apr 2026 07:00:00 GMT
• tscan therapeutics (nasdaq: tcrx) seeks big boost in authorized shares at 2026 meeting Stock Titan Fri, 17 Apr 2026 07:00:00 GMT
• needham maintains tscan therapeutics(tcrx.us) with buy rating, maintains target price $6 Moomoo Thu, 16 Apr 2026 11:51:47 GMT
• tcrx: tcr t cell therapy halves relapse rates in aml/mds, with pivotal trial and expansion planned TradingView Wed, 15 Apr 2026 20:02:34 GMT
• tcrx: tcr t cell therapy shows >50% relapse reduction in aml/mds, pivotal trial starts mid-2024 TradingView Wed, 15 Apr 2026 07:00:00 GMT
• tscan therapeutics, inc. (nasdaq:tcrx) given average rating of "hold" by analysts MarketBeat Fri, 10 Apr 2026 07:41:04 GMT
• wall street analysts are bullish on top healthcare picks The Globe and Mail Fri, 10 Apr 2026 07:00:00 GMT
• h.c. wainwright reiterates buy on tscan stock, $7 target by investing.com Investing.com Canada Thu, 09 Apr 2026 11:40:57 GMT
• tscan therapeutics to participate in the 25th annual needham virtual healthcare conference Sahm Thu, 09 Apr 2026 07:33:06 GMT
• h.c. wainwright maintains tscan therapeutics(tcrx.us) with buy rating, maintains target price $7 富途牛牛 Thu, 09 Apr 2026 07:00:00 GMT
• tscan therapeutics to participate in the 25th annual needham virtual healthcare conference GlobeNewswire Wed, 08 Apr 2026 07:00:00 GMT
• tscan to webcast needham healthcare conference fireside chat Stock Titan Wed, 08 Apr 2026 07:00:00 GMT
• tscan therapeutics (nasdaq: tcrx) seeks approval to double authorized shares to 600m Stock Titan Tue, 07 Apr 2026 20:30:19 GMT
• tscan therapeutics (nasdaq:tcrx) shares up 3% - here's what happened MarketBeat Tue, 07 Apr 2026 07:00:00 GMT
• tscan therapeutics (nasdaq:tcrx) shares up 3% – here’s what happened Defense World Tue, 07 Apr 2026 06:37:19 GMT
• market recap: will tscan therapeutics inc stock benefit from m a - 2026 technical overview & low risk profit maximizing plans baoquankhu1.vn Mon, 06 Apr 2026 15:59:32 GMT
• will tscan therapeutics (tcrx) stock recover soon | price at $1.06, up 5.45% - price surge stocks newsline.com Mon, 06 Apr 2026 07:00:00 GMT
• tcrx stock analysis: tscan therapeutics inc. biotech at $1 level following small daily dip newsline.com Fri, 03 Apr 2026 07:00:00 GMT
• tscan therapeutics consolidates finance leadership after officer resignation The Globe and Mail Fri, 03 Apr 2026 07:00:00 GMT
• tscan therapeutics announces resignation of vice president of finance Investing.com Thu, 02 Apr 2026 07:00:00 GMT
• tscan therapeutics (tcrx) cfo adds principal accounting officer role after vp finance resignation Stock Titan Thu, 02 Apr 2026 07:00:00 GMT
• tscan therapeutics consolidates finance leadership after officer resignation TipRanks Thu, 02 Apr 2026 07:00:00 GMT
• tcrx stock news today | earnings, events & price alerts Intellectia AI Sun, 29 Mar 2026 19:55:23 GMT
• tscan therapeutics (tcrx) price target decreased by 25.49% to 6.46 MSN Sat, 28 Mar 2026 23:53:08 GMT
• strong analyst sentiment on tscan therapeutics (tcrx) amid ongoing momentum in cell therapy space msn.com Sat, 28 Mar 2026 07:22:33 GMT
• strong analyst sentiment on tscan therapeutics (tcrx) amid ongoing momentum in cell therapy space MSN Fri, 27 Mar 2026 20:05:51 GMT
• strong analyst sentiment on tscan therapeutics (tcrx) amid ongoing momentum in cell therapy space MSN Thu, 26 Mar 2026 00:27:49 GMT
• tscan therapeutics (tcrx) price target increased by 10.53% to 7.14 MSN Wed, 25 Mar 2026 08:25:34 GMT
• earnings risk: will tscan therapeutics inc stock benefit from m a - 2026 price targets & weekly high potential stock alerts baoquankhu1.vn Wed, 25 Mar 2026 08:01:54 GMT
• Strong Analyst Sentiment on TScan Therapeutics (TCRX) Amid Ongoing Momentum in Cell Therapy Space Yahoo Finance Wed, 25 Mar 2026 07:00:00 GMT
Tscan Therapeutics Inc(NASDAQ:TCRX) 
TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.
Share this website to your friends